Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
David Hunter, MD, an associate professor of neurology at UTHealth Houston, not involved in this review, spoke with Medical News Today about its findings
Rahman, I., et al
There are currently around 54 million patients with a diagnosis of dementia worldwide with incidence rates predicted to triple internationally to 152 million people by 2050 and will cost health services $2 trillion a year by 2030 as per the World Alzheimer Report 2018 [3]
S.BhattacharjeeA.MajumdarU.RoyA.MaitiD.GoswamyA
Clinical studies indicate that patients using GLP-1 medications can experience a reduction of 15% to 25% of their body mass over time, particularly benefiting those battling obesity or related health issues
Data availability This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency
